Wells Fargo’s Select Medical SEM Stock Holding History

Wells Fargo’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-241,280	Closed	-$581K	–	6542
2017 Q4	$581K	Hold	241,280	–	–	﹤0.01%	4287
2017 Q3	$557K	Buy	+241,280	New	+$2.23M	﹤0.01%	4256

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Wells Fargo's SEM Position: Q2 2026 in Review

Wells Fargo increased its Select Medical (SEM) stake by 10,274% in Q2 2026, buying an estimated $73.5M and bringing the position to 4,506,456 shares worth $74.4M. The position accounts for 0.01% of the portfolio, ranked #811.

Wells Fargo first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. 241 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Wells Fargo held 4,506,456 shares of Select Medical worth $74.4M as of Q2 2026.
Wells Fargo bought 4,463,018 Select Medical shares in Q2 2026, an estimated $73.5M.
Select Medical made up 0.01% of Wells Fargo's portfolio in Q2 2026, its #811 holding.
Wells Fargo first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
241 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.